New York, NY (PRWEB) January 30, 2014
Prostate cancer is the second leading cause of cancer death in American men. One in six men will be diagnosed with prostate cancer and 230,000 new cases are diagnosed annually. Overall, the five-year survival rate is 100 percent for men with the disease confined to the prostate or nearby tissue.
Expert Available for Interview:
Ash Tewari, MBBS, MCh, Kyung Hyun Kim, MD Chair in Urology, Icahn School of Medicine at Mount Sinai and Chairman, Milton and Carroll Petrie Department of Urology at the Mount Sinai Hospital is available for media interviews. He is an internationally renowned leader in robotic prostate surgery and has performed more than 5,500 robotic prostatectomies. His novel approach (ART™) uses unique diagnostic imaging so many patients can become nerve-sparing candidates. Intra-operative nerve monitoring saves the entire nerve hammock using athermal and traction free techniques.
“Fortunately, prostate cancer can be cured if it is detected early on,” said Dr. Tewari. “At Mount Sinai, our Precision Urology ™ approach involves integration of multiple variables and imaging data in a decision support system. This is key in assuring men with prostate cancer of our commitment to a patient-centric, personalized diagnostic approach and excellent outcome, while minimizing the side effects of treatment.”
Tips for Prostate Cancer Prevention:
Age is the strongest risk factor: Almost two-thirds of prostate cancers are found in men over the age of 65.
Family history can be important: Having a father or brother with prostate cancer more than doubles a man's risk of developing this disease.
Race is a factor: Prostate cancer occurs more often in African-American men than in men of other races.
Follow a healthy diet: Eat more low-fat, high-fiber foods such as fruits and vegetables; limit intake of red or processed meat.
Diagnosing cancer early: Speak with your physician about your risk for prostate cancer and the benefits of screening. For men at high risk, screening should be considered at 40.
Screening Tests: Screenings consists of a PSA blood test which measures the level of PSA, a protein that is produced by the prostate gland and a digital rectal exam (DRE) which can uncover physical abnormalities of the prostate that may be a sign of cancer.
New Advancements in Treatment and Detection:
ART ™ (Advanced Robotic Technique) prostatectomy is a term that encompasses the robotic surgical techniques developed by Dr. Tewari and his team.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.